| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 05/11/2005 | CN1615284A Method for forming a carbon-carbon or carbon-heteroatom linkage |
| 05/11/2005 | CN1615133A Crystalline solids of carvedilol and processes for their preparation |
| 05/11/2005 | CN1614494A Electro chromotropic apparatus containing hydrazone compound |
| 05/11/2005 | CN1613857A Dipyrromethene metal chelate compounds |
| 05/11/2005 | CN1200931C Process for preparation of R-(+)-6-carboxamido-3-N-methylamino-1,2,3,4- tetrahydrocarbazole |
| 05/10/2005 | US6891989 Optical switch systems using waveguide grating-based wavelength selective switch modules |
| 05/10/2005 | US6891065 Advanced route for the synthesis of cPLA2 inhibitors |
| 05/10/2005 | US6891044 Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their use |
| 05/10/2005 | US6890938 Antiinflammatory agents |
| 05/10/2005 | US6890935 Pharmaceutical compositions and methods for use |
| 05/10/2005 | US6890921 Selectively inhibit binding to alpha-1a adrenergic receptor; 1-(2-phthalimidoethyl)-4-(2-isopropyloxyphenyl)piperazine; N-(Ethyl-2-(2-iso-propyloxyphenyl)piperazin-4-yl))-(1'-(2-oxy -piperdinyl))acetamidemide |
| 05/06/2005 | WO2005040368A2 Crystals of an aurora-a tpx2 complex, tpx2 binding site of aurora-a, aurora-a ligands and their use |
| 05/06/2005 | WO2005040355A2 Tao kinase modulators and methods of use |
| 05/06/2005 | WO2005040117A1 Carbazole derivative, light emitting element, and light emitting device |
| 05/06/2005 | WO2005040116A2 Indolinone derivatives and their use in treating disease-states such as cancer |
| 05/06/2005 | WO2005040115A1 Process for the preparation of ropinirole |
| 05/06/2005 | WO2005040114A1 Compounds having crth2 antagonist activity |
| 05/06/2005 | WO2005040113A1 Processes for the preparation of a polymorph of fluvastatin sodium |
| 05/06/2005 | WO2005040112A1 Compounds with pgd2 antagonist activity |
| 05/06/2005 | WO2005040111A2 Combinatorial library of 3-aryl-1h-indole-2-carboxylic acids |
| 05/06/2005 | WO2005040102A2 Novel compounds and their use as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them |
| 05/06/2005 | WO2005040101A1 Acylurea connected and sulfonylurea connected hydroxamates |
| 05/06/2005 | WO2005040100A1 Tetrahydro-naphthalene and urea derivatives |
| 05/06/2005 | WO2005040095A1 Inhibitors of dipeptidyl peptidase iv |
| 05/06/2005 | WO2005040073A2 Solid phase synthesis of 3-aryl-2- indolylcarboxylic acids |
| 05/06/2005 | WO2005039564A1 Phthalimide compounds useful as protein kinase inhibitors |
| 05/06/2005 | WO2005039546A2 Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases |
| 05/06/2005 | WO2005012249A3 Adamantyglycine- based inhibitors of dipeptidyl peptidase iv for the treatment of diabetes |
| 05/06/2005 | WO2004113394A3 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom |
| 05/06/2005 | WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 05/06/2005 | CA2543570A1 Acylurea connected and sulfonylurea connected hydroxamates |
| 05/06/2005 | CA2542720A1 Azabenzodiazepines as phosphodiesterase-4 inhibitors |
| 05/06/2005 | CA2542716A1 Compounds having crth2 antagonist activity |
| 05/06/2005 | CA2542494A1 Tetrahydro-naphthalene and urea derivatives |
| 05/06/2005 | CA2542064A1 Tao kinase modulators and methods of use |
| 05/06/2005 | CA2541720A1 Processes for the preparation of a polymorph of fluvastatin sodium |
| 05/06/2005 | CA2541460A1 Indolinone derivatives and their use in treating disease-states such as cancer |
| 05/06/2005 | CA2541090A1 Use of indole acetic acid or derivatives thereof to increase igf-1 serum levels |
| 05/06/2005 | CA2540810A1 Crystals of an aurora-a tpx2 complex, tpx2 binding site of aurora-a, aurora-a ligands and their use |
| 05/05/2005 | US20050096377 Substituted sulfonamide-indoles |
| 05/05/2005 | US20050096375 through augmentation of glutamatergic neurotransmission; Central nervous system disorders, cognitive disorders, schizophrenia, dementia; 3-aza-bicyclo[3.1.0]hexanes; Thiophene-2-carboxylic acid (3-cyclohexylmethyl-3-aza-bicyclo[3.1.0]hex-6-ylmethyl)-(3-fluoro-4-morpholin-4-yl-phenyl)-amide |
| 05/05/2005 | US20050096355 Novel immunotherapeutic agents |
| 05/05/2005 | US20050096330 N-(indolecarbonyl) piperazine derivatives |
| 05/05/2005 | US20050096321 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates |
| 05/05/2005 | US20050096317 Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives |
| 05/05/2005 | US20050095518 photoconductive element with bis(hydrazone) carbazole compounds of given formula as charge transport material; electrophotographic apparatus and imaging method; good electrostatic properties |
| 05/05/2005 | US20050095517 electroconductive substrates having photoconductors comprising charge generating compound and charge transfer compounds having hydrazone and vinyl ether groups; electrostatics; printers; copiers |
| 05/05/2005 | CA2486015A1 Novel amino acid derivative and sweetening agent |
| 05/04/2005 | EP1528062A2 Process for the preparation of s-type 4-substituted hydroxypyranoindolidine compounds |
| 05/04/2005 | EP1527047A1 3-z- 1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-me thyl-amino)-anilino)-1-phenyl-methylene -6-methoxycarbonyl-2 -indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition |
| 05/04/2005 | EP1527046A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 05/04/2005 | EP1225895B1 Fab i inhibitors |
| 05/04/2005 | CN1612881A Polymerization catalyst activator and its use in a polymerization process |
| 05/04/2005 | CN1612876A Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1] octane, the preparation thereof and the application of same in therapeutics |
| 05/04/2005 | CN1612856A 1, 3-diarylprop-2-en-1-ones, compositions containing same and use thereof |
| 05/04/2005 | CN1612732A Analgesics and methods of use |
| 05/04/2005 | CN1612062A Organophotoreceptor with a hydrazone polymer charge transport material |
| 05/04/2005 | CN1612060A Organophotoreceptor with charge transport material having a vinyl ether group |
| 05/04/2005 | CN1612059A Organophotoreceptor with charge transport material having three arylamino groups |
| 05/04/2005 | CN1199946C Specific indole compound and its preparation and use in treating and preventing cancers |
| 05/04/2005 | CN1199931C Naphthalene alizarine derivatives, preparing method and use thereof |
| 05/03/2005 | US6888032 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 05/03/2005 | US6888029 Arylation complex catalyst |
| 05/03/2005 | US6888027 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| 05/03/2005 | US6887892 Tricyclic derivatives of indole with antiangiogenic activity |
| 05/03/2005 | US6887890 For therapy of thrombocytopenia |
| 05/03/2005 | US6887863 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors |
| 05/03/2005 | US6887854 Absorption, fluorescence; using light for optical medical diagnosis |
| 05/03/2005 | US6887634 Charge transfer compounds has hydrazone-bridged (N,N-disubstituted)arylamine groups connected by a central bridging group; photoimaging |
| 05/03/2005 | CA2297486C 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor |
| 04/28/2005 | WO2005037834A1 NOVEL TETRAYDROSPIRO{PIPERIDINE-2,7’ -PYRROLO[3,2-b]PYRIDINE DERIVATIVES AND NOVEL INDOLE DERIVATIVES USEFUL IN THE TREATMENT OF 5-HT6 RECEPTOR -RELATED DISORDERS |
| 04/28/2005 | WO2005037809A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 04/28/2005 | WO2005037807A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
| 04/28/2005 | WO2005037791A1 Compositions and methods for viral inhibition |
| 04/28/2005 | WO2005037790A1 Preparation of 3-azabicyclo [3.1.0] hexane derivatives |
| 04/28/2005 | WO2005037789A1 Phthalimide herbicides |
| 04/28/2005 | WO2005037788A1 Novel method for preparation of crystalline perindopril erbumine |
| 04/28/2005 | WO2005037787A1 Crystalline form of fluvastatin sodium |
| 04/28/2005 | WO2005037283A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 04/28/2005 | WO2005037282A1 1-alkylpiperazinyl-pyrrolidin-2,5-dione derivatives as adrenergic receptor antagonists |
| 04/28/2005 | WO2005037281A1 1-alkylpiperazinyl-pyrrolidin-2, 5-dione derivatives as adrenergic receptor antagonist |
| 04/28/2005 | WO2005037279A1 1- 2’ (1, 4’-biperidin-1’-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms |
| 04/28/2005 | WO2005037216A2 Bicyclic [3.1.0] derivatives as glycine transporter inhibitors |
| 04/28/2005 | WO2005037207A2 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 04/28/2005 | WO2005002293A3 Cox-2-targeted imaging agents |
| 04/28/2005 | WO2004014842A8 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 04/28/2005 | US20050090559 Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents |
| 04/28/2005 | US20050090541 Indolinone derivatives and their use in treating disease-states such as cancer |
| 04/28/2005 | US20050090539 Intermediates for making 1(alpha-amino-1-(cyclopropyl-fused pyrrolidinylcarbonyl)methyl)-3-hydroxyadamantanes, e.g., methyl 3-hydroxy-<a-oxotricyclo[3.3.1.13,7]decane-1-acetate |
| 04/28/2005 | US20050090523 2-(substituted phenyl)imidazo[1,2-a]pyridine compounds; use to treat disorders mediated by the histamine H3 receptor such as sleep disorders, attention deficit hyperactivity disorder, or Alzheimer's disease; 2-[4-[3-(Piperidino)propylamino]phenyl]-8-methylimidazo[1,2-a]pyridine for example |
| 04/28/2005 | US20050090516 Novel substituted imides |
| 04/28/2005 | US20050090498 3-Quinolin-2(1h)-ylideneindolin-2-one derivative |
| 04/28/2005 | US20050090485 7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders |
| 04/28/2005 | US20050090400 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 04/28/2005 | US20050090381 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 04/28/2005 | US20050089936 Such as 5-chloro-3-phenyl-1H-indole-2-carboxylic acid benzylamide; immobilization; drug screening |
| 04/28/2005 | US20050089935 Combinatorial library of 3-aryl-1h-indole-2-carboxylic acid |
| 04/28/2005 | US20050089783 Organophotoreceptor with a hydrazone polymer charge transport material |
| 04/28/2005 | US20050089493 Spermine peptide surfactants with amide or amine bonds for surfactants used to transfer cells |
| 04/28/2005 | CA2549733A1 Fused-aryl and heteroaryl derivatives and methods of their use |